Resistance to Chemotherapy Drug Oxaliplatin:A Bioinformatics Summary
محل انتشار: اولین کنگره بین المللی ژنومیک سرطان
سال انتشار: 1402
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 88
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
CGC01_030
تاریخ نمایه سازی: 29 آبان 1402
چکیده مقاله:
Background: Oxaliplatin is a commonly used chemotherapydrug for treating various types of cancers. However, some patientsdevelop resistance to this drug, which hinders its effectiveness.Identification of the molecular pathways involved indrug resistance can aid in the development of novel therapeuticstrategies.Materials and Methods: RNA sequencing data wasanalyzed, and several genes were identified to be involved inthe molecular pathways of drug resistance. Results: The analysisrevealed the involvement of several genes, including NRF۲,MRP۲, and ABCG۲, in the molecular pathways of drug resistance.These genes play a role in cellular detoxification and drugefflux, which can lead to reduced drug efficacy.Conclusion: Theidentification of molecular pathways involved in drug resistancecan help researchers develop novel strategies to combatdrug resistance and improve the effectiveness of chemotherapytreatments.
کلیدواژه ها:
نویسندگان
Zeinab Mohtajollah
Department of Molecular Genetics, Faculty of Biological Science,Tarbiat Modares University, Tehran, Iran
Seyyed Roham Mohamad Nejad Kenari
Ebne Sina institude